SecurityTEDU / Tarena International, Inc. (876108101)
Institutional Owners58
Institutional Shares21,477,696
Institutional Value$ 217,505,000 USD

Institutional Stock Ownership and Shareholders()

TEDU / Tarena International, Inc. Institutional Ownership

Tarena International, Inc. (NASDAQ:TEDU) has 58 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 21,477,696 shares. Largest shareholders include Davis Selected Advisers, Wellington Management Group LLP, Schroder Investment Management Group, Alliancebernstein L.p., Ho Chi Sing, FIL Ltd, Greenwoods Asset Management Ltd, Dalton Investments LLC, BlackRock Inc., and Sensato Investors LLC.
Tarena International, Inc. (NASDAQ:TEDU) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/tedu"><img src="https://images.fintel.io/us-tedu-so.png" alt="TEDU / Tarena International, Inc. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-15 13F-HR Marshall Wace LLP 17,180 0 -100.00 258 0 -100.00
2018-05-15 13F-HR DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 363,213 363,213 0.00 5,444 4,075 -25.15
2018-05-15 13F-HR AQR CAPITAL MANAGEMENT LLC 20,488 20,488 0.00 307 230 -25.08
2018-05-15 13F-HR TWO SIGMA INVESTMENTS LLC 92,953 47,758 -48.62 1,393 536 -61.52
2018-06-28 13F-HR/A BROWN ADVISORY INC 192,400 0 -100.00 2,884 0 -100.00
2018-05-11 13F-HR CITADEL ADVISORS LLC 54,171 608
2018-05-10 13F-HR TORONTO DOMINION BANK 32 0
2018-05-15 13F-HR Invesco Ltd. 62,583 65,516 4.69 938 735 -21.64
2018-05-15 13F-HR D. E. Shaw & Co., Inc. 40,099 34,662 -13.56 601 389 -35.27
2018-05-11 13F-HR HSBC HOLDINGS PLC 40,000 40,000 0.00 600 449 -25.17
2018-05-15 13F-HR GUGGENHEIM CAPITAL LLC 29,394 31,267 6.37 441 351 -20.41
2018-05-14 13F-HR LAZARD ASSET MANAGEMENT LLC 300 300 0.00 4 3 -25.00
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 0 389,731 0 4,373
2018-05-15 13F-HR Ashmore Group plc 86,001 89,386 3.94 1,290 1,003 -22.25
2017-02-10 13F-HR BlackRock Fund Advisors 14,254 170,615 1,096.96 206 2,558 1,141.75
2018-05-09 13F-HR NORTHERN TRUST CORP 90,190 48,878 -45.81 1,352 550 -59.32
2018-05-15 13F-HR TWO SIGMA ADVISERS, LP 174,800 172,000 -1.60 2,620 1,930 -26.34
2018-05-15 13F-HR Wellington Management Group LLP 2,104,895 2,670,493 26.87 31,552 29,964 -5.03
2018-05-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 22,200 0 -100.00 333 0 -100.00
2018-05-14 13F-HR MORGAN STANLEY 87,014 10,591 -87.83 1,304 118 -90.95
2018-05-03 13F-HR Trexquant Investment LP 0 13,433 0 151
2018-05-14 13F-HR PROFUND ADVISORS LLC 18,975 0 -100.00 284 0 -100.00
2018-05-15 13F-HR CREDIT SUISSE AG/ 35,650 35,716 0.19 535 401 -25.05
2018-05-10 13F-HR MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 264,200 0 -100.00 3,960 0 -100.00
2018-05-15 13F-HR HBK INVESTMENTS L P 0 23,300 0 261
2018-05-17 13F-HR Legal & General Group Plc 4,738 4,738 0.00 71 53 -25.35
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 189 0 -100.00 3 0 -100.00
2018-05-14 13F-HR Greenwoods Asset Management Ltd 1,072,375 1,072,375 0.00 16,075 12,032 -25.15
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 965 2,603 169.74 14 29 107.14
2018-05-15 13F-HR STATE STREET CORP 171,751 151,701 -11.67 2,573 1,700 -33.93
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 14,364 54,171 277.13 268 608 126.87
2018-05-15 13F-HR DEUTSCHE BANK AG\ 9,071 35,103 286.98 135 393 191.11
2018-05-15 13F-HR VANGUARD GROUP INC 13,020 18,765 44.12 195 211 8.21
2018-05-15 13F-HR Advisor Group, Inc. 368 28 -92.39 5 0 -100.00
2018-05-10 13F-HR JP Morgan Chase & Co 0 106,889 0 1,199
2018-05-14 13F-HR DAVIS SELECTED ADVISERS 4,347,615 4,862,181 11.84 65,171 54,554 -16.29
2018-05-15 13F-HR BARCLAYS PLC 0 5 0 0
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 119,029 177,527 49.15 1,724 2,661 54.35
2018-05-08 13F-HR US BANCORP \DE\ 2,478 2,979 20.22 37 33 -10.81
2018-05-02 13F-HR Daiwa Securities Group Inc. 84,200 2,700 -96.79 1,573 30 -98.09
2018-05-15 13F-HR Sensato Investors LLC 850,416 594,254 -30.12 12,748 6,668 -47.69
2017-02-13 SC 13G/A GOLDMAN SACHS ASSET MANAGEMENT, L.P. 5,457,426 542,052 -90.07
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 19,524 0 -100.00 219 0 -100.00
2018-07-10 13F-HR Copper Rock Capital Partners, LLC 446,626 0 -100.00 5,011 0 -100.00
2017-05-15 13F-HR Serenity Capital Management, Ltd 176,082 0 -100.00 2,639 0 -100.00
2018-05-14 13F-HR ALLIANCEBERNSTEIN L.P. 2,536,518 1,853,373 -26.93 38,022 20,795 -45.31
2018-05-15 13F-HR Bank of New York Mellon Corp 199,418 246,343 23.53 2,989 2,763 -7.56
2018-05-15 13F-HR MARSHALL WACE ASIA Ltd 153,646 0 -100.00 2,303 0 -100.00
2018-04-17 13F-HR BENJAMIN F. EDWARDS & COMPANY, INC. 1,265 14
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 1,277 1,277 0.00 19 14 -26.32
2018-05-08 13F-HR Parallel Advisors, LLC 299 299 0.00 4 3 -25.00
2018-05-11 13F-HR CITIGROUP INC 7,016 0 -100.00 105 0 -100.00
2018-05-15 13F-HR UBS Group AG 19,498 5,177 -73.45 292 58 -80.14
2018-05-14 13F-HR NORDEA INVESTMENT MANAGEMENT AB 155,963 164,453 5.44 2,338 1,845 -21.09
2018-05-11 13F-HR DIMENSIONAL FUND ADVISORS LP 406,379 407,279 0.22 6,089 4,570 -24.95
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 2,428 8,553 252.27 36 96 166.67
2018-05-11 13F-HR MACQUARIE GROUP LTD 2,046,575 0 -100.00 27,388 0 -100.00
2018-04-25 13F-HR PICTET ASSET MANAGEMENT LTD 14,800 14,800 0.00 222 166 -25.23
2018-05-03 13F-HR/A Parametrica Management Ltd 140,848 173,784 23.38 2,111 1,950 -7.63
2018-05-14 13F-HR BB&T SECURITIES, LLC 16,276 33,390 105.15 243 374 53.91
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 142,900 142,900 0.00 2,142 1,603 -25.16
2018-05-08 13F-HR Smith Asset Management Group LP 6,990 6,754 -3.38 105 76 -27.62
2018-05-14 13F-HR Meiji Yasuda Asset Management Co Ltd. 111,200 0 -100.00 1,667 0 -100.00
2018-05-02 13F-HR DUPONT CAPITAL MANAGEMENT Corp 9,897 8,680 -12.30 148 97 -34.46
2017-02-10 13F-HR BlackRock Group LTD 58,330 66,439 13.90 845 996 17.87
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 27,518 42,492 54.42 412 476 15.53
2017-02-10 SC 13G/A Ho Chi Sing 3,368,837 1,689,190 -49.86 0 -100.00
2018-05-14 13F-HR Renaissance Technologies LLC 276,700 391,005 41.31 4,148 4,387 5.76
2018-05-09 13F-HR BlackRock Inc. 561,606 617,624 9.97 8,419 6,930 -17.69
2018-05-14 13F-HR Dalton Investments LLC 250,200 624,600 149.64 3,750 7,008 86.88
2018-05-14 13F-HR FIL Ltd 1,427,919 1,205,405 -15.58 21,405 13,525 -36.81
2018-05-15 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 19,400 0 -100.00 291 0 -100.00
2018-05-11 13F-HR/A SCHRODER INVESTMENT MANAGEMENT GROUP 1,723,695 1,862,993 8.08 25,838 20,903 -19.10

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

49m - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

22h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

The New Wave Of Education

2018-07-11 seekingalpha
Since China enacted the Compulsory Education Law in 1986, the literacy rate has jumped from roughly 74% to over 96%. (1-0)

Tarena International, Inc (TEDU) CEO Shaoyun Han on Q1 2018 Results - Earnings Call Transcript

2018-06-06 seekingalpha
Ladies and gentlemen, thank you for standing by. And welcome to Tarena International, Inc. First Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. After management’s prepared remarks, there will be a question-answer-session. Today's conference is being recorded. If you have any objections, you may disconnect at any time. (6-0)

Tarena International, Inc. 2018 Q1 - Results - Earnings Call Slides

2018-06-05 seekingalpha
The following slide deck was published by Tarena International, Inc. in conjunction with their 2018 Q1 earnings call. (6-1)

CUSIP: 876108101